These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31176793)

  • 1. Sugar in mind: Untangling a sweet and sour relationship beyond type 2 diabetes.
    Cherbuin N; Walsh EI
    Front Neuroendocrinol; 2019 Jul; 54():100769. PubMed ID: 31176793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exercise on type 2 diabetes-associated cognitive impairment in rats.
    Mehta BK; Singh KK; Banerjee S
    Int J Neurosci; 2019 Mar; 129(3):252-263. PubMed ID: 30231786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration in diabetes mellitus.
    Umegaki H
    Adv Exp Med Biol; 2012; 724():258-65. PubMed ID: 22411248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA
    Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.
    Alosco ML; Gunstad J
    Curr Diab Rep; 2014 Jun; 14(6):495. PubMed ID: 24752836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartame: Should Individuals with Type II Diabetes be Taking it?
    Choudhary AK
    Curr Diabetes Rev; 2018; 14(4):350-362. PubMed ID: 28571543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
    Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
    Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of type 2 diabetes in neurodegeneration.
    Verdile G; Fuller SJ; Martins RN
    Neurobiol Dis; 2015 Dec; 84():22-38. PubMed ID: 25926349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline.
    Walker JM; Harrison FE
    Nutrients; 2015 Sep; 7(9):7332-57. PubMed ID: 26340637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
    Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.
    Brook E; Mamo J; Wong R; Al-Salami H; Falasca M; Lam V; Takechi R
    Pharmacol Res; 2019 Mar; 141():291-297. PubMed ID: 30616019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.
    Duarte AI; Candeias E; Correia SC; Santos RX; Carvalho C; Cardoso S; Plácido A; Santos MS; Oliveira CR; Moreira PI
    Biochim Biophys Acta; 2013 Apr; 1832(4):527-41. PubMed ID: 23314196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review.
    Maresch CC; Stute DC; Alves MG; Oliveira PF; de Kretser DM; Linn T
    Hum Reprod Update; 2018 Jan; 24(1):86-105. PubMed ID: 29136166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies.
    Luo A; Xie Z; Wang Y; Wang X; Li S; Yan J; Zhan G; Zhou Z; Zhao Y; Li S
    Neurosci Biobehav Rev; 2022 Jun; 137():104642. PubMed ID: 35367221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and pathological brain ageing.
    Cholerton B; Baker LD; Craft S
    Diabet Med; 2011 Dec; 28(12):1463-75. PubMed ID: 21974744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.